Navigation Links
Novation Commends the White House for Its Support and Advancement of Solutions for American Hospitals' Drug Shortage Crisis
Date:11/2/2011

IRVING, Texas, Nov. 2, 2011 /PRNewswire/ -- Novation commends the White House for raising awareness of the drug shortage crisis facing America's hospitals through its October 31st Executive Order.  

The Order, along with the announced support of the bipartisan legislation – (S. 296 and H.R. 2245) – currently pending in Congress, should begin to establish a framework by which the quality and resiliency of the pharmaceutical supply chain can be improved.  The Order is especially important in that it calls upon both the manufacturer community and the Food and Drug Administration itself to take steps to improve the current emergency situation through improved reporting of potential shortages and well as implementation of expedited regulatory review where possible.  

The drug shortages facing America's hospitals remain at critical levels and continue to impact both patients and providers.  Cooperation throughout the industry is necessary to improve this situation, and measures such as the President's Order and the proposed legislation will help alleviate the problem.

Novation is committed to continue working closely with the FDA, drug manufacturers, and other GPOs to help hospitals access necessary pharmaceuticals.  

About Novation

Founded in 1998, Novation is the leading health care supply contracting company for more than 25,000 members of VHA Inc. and UHC, two national health care alliances, and 5,500 members of Provista, LLC, representing more than 30,000 sites. Novation provides alliance members sourcing and information and data services. Based in Irving, Texas, Novation develops and manages competitive contracts with more than 600 suppliers. VHA, UHC and Provista members used Novation contracts to purchase approximately $40 billion in 2010.  More information about Novation can be found at www.novationco.com.


'/>"/>
SOURCE Novation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. joimax® Launches Numerous Innovations at NASS Chicago From November 2 - 4, 2011
2. FDA Invests $2 Million in Partnerships Through Centers of Excellence in Regulatory Science and Innovation
3. Aethlon Medical to Present at IN3 Medical Innovation Summit on October 27th
4. PharmaSecure, an Innovator in Pharmaceutical Serialization, Closes $3.9M Investment by Eric Schmidts Innovation Endeavors, Gray Ghost Ventures, Healthtech Capital and the TEEC Angel Fund
5. Waters Recognizes the Dr. Ganesh Anand Laboratory at the National University of Singapore as Center of Innovation
6. TEDMED to Highlight Patient Care and Physician Training Advancements in Innovations Showcase
7. Young Innovations, Inc. Announces Record EPS for the Quarter and Record Sales and EPS for the Nine-Months Ended September 30, 2011 and Declares Quarterly Dividend
8. Young Innovations, Inc. Board of Directors Declares Special Cash Dividend
9. Pew Supports Antibiotics Innovation Bill in Senate
10. Ion Torrent CEO Jonathan Rothberg, Life Technologies Recognized by Wall Street Journal Technology Innovation Awards for the Ion Personal Genome Machine
11. Young Innovations, Inc. Provides 3rd Quarter Conference Call Details
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... Research and Markets has announced the addition of the ... to their offering. ... The ablation device global market is expected to grow at ... Ablation is the minimally invasive therapeutic tissue excision procedure ... tissue removal, to the removal of abnormally conducting cardiac tissue in ...
(Date:3/29/2017)...   Royal Philips (NYSE: PHG, AEX: ... PathAI, a company that develops artificial intelligence technology ... develop solutions that improve the precision and accuracy ... The partnership aims to build deep learning applications ... intelligence to be applied to massive pathology data ...
(Date:3/29/2017)... , March 29, 2017 On March 28, the U.S. ... adult patients with relapsing forms of multiple sclerosis (MS) ... first drug approved by the FDA for PPMS. Ocrevus ... professional.  "Multiple sclerosis can have a ... Dunn , M.D., director of the Division of Neurology ...
Breaking Medicine Technology:
(Date:3/29/2017)... MD (PRWEB) , ... March 29, 2017 , ... ... is proud to announce the finalization of the company’s executive management team with prominent ... and leading operations is Curio Wellness’ Chief Operating Officer, Ted Dumbauld , who ...
(Date:3/29/2017)... Linda, Ca (PRWEB) , ... March 29, 2017 , ... ... of a growing number of cancers and is touted to be the next revolution ... treatment, thus far, has been in the form of immune checkpoint inhibitors such as ...
(Date:3/29/2017)... ... 29, 2017 , ... The Wharton School of the University of Pennsylvania is ... made a $10 million gift to establish the Ken Moelis and Julie Taffet ... to a Wharton MBA for highly-qualified Penn undergraduates whose academic and career interests expand ...
(Date:3/28/2017)... CA (PRWEB) , ... March 28, 2017 , ... Tuesday, ... asking the American public to take the Diabetes Risk Test to find out if ... the Los Angeles World Airports will light up the evening sky by programming the ...
(Date:3/28/2017)... ... March 28, 2017 , ... Resoundant, ... be invited to the Siemens Healthineers annual customer education symposium, a world-class learning ... take place from March 27 - 31, 2017 at the Atlanta Marriott Marquis ...
Breaking Medicine News(10 mins):